Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

New Johnson & Johnson’s Q3 Earnings Beat Street View, Raises Annual Outlook

By Vandana Singh
October 17, 7:53 AM
Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse

JNJ

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

FDA Approves Merck’s Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication

By Vandana Singh
October 17, 7:28 AM
The FDA approved Merck & Co Inc's (NYSE: MRK) Keytruda for resectable (tumors ≥4 centimeters [cm] or node-positive) non-small cell lung cancer (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant treatment and then continued as a single agent as adjuvant 

AZN

Read More
1 minute read
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News

Rio Tinto’s Pilbara Mine Q3 Iron Ore Production Slips 1%

By Lekha Gupta
October 17, 6:51 AM
Rio Tinto PLC (NYSE: RIO) provided the production update for Q3 FY23.

RIO

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Contracts
  • Large Cap
  • Management
  • Offerings
  • Politics
  • Top Stories

Bill Ford’s Plea To End UAW Strike, Analysts See Near-Term Buying Opportunity On US Automaker Stocks

By Piero Cingari
October 16, 5:01 PM
Bill Ford encourages union leaders and members to work together with the company to reach a resolution, as CNBC reported.

F

Read More
2 minute read
  • Asia
  • Equities
  • ETFs
  • Global
  • Hedge Funds
  • Large Cap
  • Markets
  • Politics
  • Specialty ETFs
  • Top Stories

Latest On Israel: Blinken, Netanyahu Shelter In Bunker During Air Raid Sirens, Pentagon Issues Warning To 2,000 US Troops

By Piero Cingari
October 16, 3:38 PM
U.S. Secretary of State Antony Blinken and Israeli Prime Minister Benjamin Netanyahu experienced a tense moment during their…

CELJF

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas

US Residential Solar Demand May Curb Growth Trajectory Of Enphase Energy: Analyst

By Lekha Gupta
October 16, 3:03 PM
BMO Capital Markets analyst Ameet Thakkar downgraded Enphase Energy Inc (NASDAQ: ENPH) to Market Perform from Outperform at a 

ENPH

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • Equities
  • Large Cap
  • M&A
  • Markets
  • News
  • Top Stories

Analyst Favors Exxon Mobil Deal, But Downgrades Pioneer Natural Resources: Here’s Why

By Lekha Gupta
October 16, 12:38 PM
BMO Capital Markets analyst Phillip Jungwirth downgraded Pioneer Natural Resources Co (NYSE: PXD) to 

PXD

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Pfizer, Sanofi’s Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants

By Vandana Singh
October 16, 12:16 PM
As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Abrysvo, to pregnant patients and Sanofi SA's (NASDAQ: 

AZN

Read More
1 minute read
  • Earnings
  • Equities
  • Large Cap
  • Markets
  • News

HDFC Q2 Net Profit Jumps Over 50%, First Quarterly Results Post Housing Finance Arm Merger

By Lekha Gupta
October 16, 12:08 PM
HDFC Bank Ltd (NYSE: HDB) reported a Q2 consolidated net revenue increase of 114.8% Y/Y to 

HDB

Read More
2 minute read
  • Financing
  • Large Cap

Goldman Sachs, Bank Of America Q3 Earnings Preview: Will Big Banks Maintain Their Momentum?

By Piero Cingari
October 16, 11:25 AM
Goldman Sachs Group Inc. (NYSE:BAC) are set to unveil their third-quarter earnings ahead of Tuesday’s market opening. Last…

BAC

Posts pagination

Previous 1 … 190 191 192 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service